Navigation Links
Agendia Opens CLIA-Registered U.S. Genomics Laboratory
Date:5/26/2009

Bender has served as Medical Director of the Hematology/Oncology Program at Quest Diagnostics, Director of Medical Oncology and Hematology at Kaiser Permanente Medical Group, Director of Strategic Development in Medical Oncology/Hematology at Johnson & Johnson, and as an investigator at the National Cancer Institute and Scripps Clinic and Research Foundation. Currently, Dr. Bender serves as an expert reviewer in oncology for the Medical Board of California, co-Editor of Anti-Cancer Drugs, an international journal on anti-cancer agents, and as a clinical instructor in medicine at the University of California, Irvine School of Medicine.

Mr. Forche brings more than 18 years of sales, marketing and commercial leadership experience in the diagnostics arena. Prior to joining Agendia, Mr. Forche was the Senior Vice President of Sales and Marketing for Insight Health Corporation, a national leader in diagnostic imaging services. He also served as Vice President of Marketing at US LABS, an industry leader in cancer diagnostic and genomic testing services, and has held sales and marketing management roles at Ventana Medical Systems (now Roche) and Abbott Laboratories.

Mr. Carter joins Agendia with 25 years of global business development experience from a number of top-tier life sciences companies such as BioTrove, Celera, Applied Biosystems, and Perkin Elmer. At Agendia, he oversees ongoing strategic alliances within the bio-pharmaceutical sector and collaboration with partners interested in Agendia's expanding molecular diagnostics portfolio.

Chynel Henning, M.D., Ph.D., FASCP, FCAP, joins Agendia with more than 30 years of experience as a laboratory director. He is currently also Director of National Cyto-Path Laboratories and Professional Pathology Medical Group Laboratory, both in Long Beach, California; and Director of the Laboratory and Department of Pathology at the Miracle Mile Medical C
'/>"/>

SOURCE Agendia B.V.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Agendia to Present Multiple Predictive and Prognostic Studies on Breast and Colorectal Cancers at ASCO Annual Meeting
2. Agendia to Present at BioCenturys Future Leaders in the Biotech Industry Conference
3. Agendia Presents Data Supporting MammaPrints Predictive and Prognostic Power at 2009 St. Gallen Breast Cancer Conference
4. Agendia Appoints Seasoned Diagnostics Executive Albert A. Luderer to Supervisory Board
5. Agendia Publishes Direct Evidence That MammaPrint Predicts Benefit of Chemotherapy in Breast Cancer
6. Agendia Appoints VP of Business Development
7. Agendias Breast Cancer Test MammaPrint(R) Standard of Care at Netherlands Cancer Institute - AVL
8. Agendia Appoints New Chief Financial Officer
9. Agendia and Ferrer Announce Exclusive Agreement for Sales of Cancer Diagnostic Services in Four Major European Markets
10. Agendias MammaPrint(R) Receives Prestigious Award From Dutch Innovation Platform
11. Agendia and Agilent Announce Plans to Jointly Develop New Diagnostic Tests, Extend Supply Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... miRagen Therapeutics, Inc., a biopharmaceutical company focused on ... for cardiovascular and muscle disease, today announced the ... a crucial role in the progression of amyotrophic ... in neuromuscular synaptic regeneration in mice. The ... the journal Science , reveal miR-206 as ...
(Date:12/11/2009)... Boston College researchers have observed the "hot electron" effect ... successfully harvested the elusive charges using ultra-thin solar cells, ... the authors report in the current online edition of ... captured in solar cells, it generates free electrons in ... snare these charges, the electrons must reach the bottom ...
(Date:12/11/2009)... 11 Algeta ASA (OSE: ALGETA), ... clinical center in the,US, the Tulane Cancer ... the phase III clinical study of Alpharadin ... prostate cancer,(CRPC) that has metastasized to the ... ALSYMPCA (ALpharadin in SYMptomatic Prostate CAncer) study ...
(Date:12/11/2009)... Gwathmey, Inc., a pre-clinical contract research ... aureus, and cardiovascular disease announces a new CEO. ... Rosalie Dunn, Ph.D., has joined Gwathmey as Chief ... years of experience working with small businesses and ... Dr. Dunn managed multimillion dollar portfolios for the ...
Breaking Biology Technology:miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2Elusive 'hot' electrons captured in ultra-thin solar cells 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer 2
... William C Heiser, PhD and Ma Theresa Redila-Flores, Bio-Rad Laboratories, , ... , ... assessment of viable cell number and proliferation , ... are necessary and useful for analysis of growth factor activity, ...
... by G.H. Goldman, R. Geremia, M. Van,Montagu, and A. Herrera-Estrella, Laboratorium voor,Genetica, Rijksuniversiteit ... Introduction , ... , a high concentration of polyethylene ... period of exposure to DNA. However, electroporation could also be useful , ...
... Maren Bell and Robert Mortimer, Human Genome Center, Division,of Cell and Molecular ... , Introduction , ... chromosomes (YACs) has traditionally , been ... is complicated, often unreliable, and transformation efficiencies are ...
Other Biology Technology:Cell Proliferation Assay Using the Benchmark Plus Microplate Spectrophotometer 2Cell Proliferation Assay Using the Benchmark Plus Microplate Spectrophotometer 3Transformation of Filamentous Fungi by High-Voltage Electroporation 2Transformation of Filamentous Fungi by High-Voltage Electroporation 3Transformation of Filamentous Fungi by High-Voltage Electroporation 4Transformation of Filamentous Fungi by High-Voltage Electroporation 5Transformation of Filamentous Fungi by High-Voltage Electroporation 6Transformation of Filamentous Fungi by High-Voltage Electroporation 7Transformation of Filamentous Fungi by High-Voltage Electroporation 8Electroporation of Yeast Artificial Chromosomes 2Electroporation of Yeast Artificial Chromosomes 3Electroporation of Yeast Artificial Chromosomes 4
(Date:12/11/2009)... and initiate different survival strategies say they have gained ... affect their health, wealth and the fate of others ... the early online edition of the journal Proceedings ... when the scientists applied the mathematical techniques used in ... proteins that colonies of bacteria rely upon to initiate ...
(Date:12/11/2009)... nearly two decades, Ivy Pike, an associate professor of ... ethnic groups in rural northern Kenya to understand how ... living there. , The results of her and her ... in three pastoralist communities of northern Kenya: A conceptual ... Social Science and Medicine , in collaboration with ...
(Date:12/11/2009)... Arno Motulsky, the senior editor of the 4th edition ... Human Genetics, was recently given the Victor A. McKusick ... contributions to the field of human genetics, was presented ... American Society of Human Genetics on 24 October 2009 ... Medicine and Genome Sciences at the University of Washington ...
Breaking Biology News(10 mins):Bacteria provide new insights into human decision making 2Bacteria provide new insights into human decision making 3Bacteria provide new insights into human decision making 4Bacteria provide new insights into human decision making 5UA-led study grapples with health effects of low-intensity warfare 2Bad Air Day Alert 3A Outdoor Air Pollutants at High Level 54653 1Bad Air Day Alert 3A Outdoor Air Pollutants at High Level 54653 2Bad Air Day Alert 3A Outdoor Air Pollutants at High Level 54653 3Developmental language disorders at preschool age 3A no proof of benefit from screening 54648 1Developmental language disorders at preschool age 3A no proof of benefit from screening 54648 2Developmental language disorders at preschool age 3A no proof of benefit from screening 54648 3Study supports DNA repair blocker research in cancer therapy 9597 1Study supports DNA repair blocker research in cancer therapy 9597 2Study supports DNA repair blocker research in cancer therapy 9597 3
... a lot of negative health news, but in the July ... rats suggests that trans-fats do not increase the risk of ... area of concern. , Epidemiological studies indicate that chronic ... unusual molecular shapes can reduce muscle,s ability to burn energy; ...
... July 8, 2008) A new partnership between the ... Development (ORD) and the Gund Institute for Ecological Economics ... more accurately determine the costs and benefits of actions ... of nature such as clean air and water, erosion ...
... In a collaborative project scientists from the Max-Planck-Institute for ... with a business in Munich, Germany and Ann Arbor, ... to generate an unprecedented view at the human transcriptome. ... lines revealed so far unrecognized complexity and variability of ...
Other Biology News:US EPA, UVM's Gund Institute team up to develop new ways to understand ecosystem services 2Deep sequencing study reveals new insights into human transcriptome 2
... Shakers have the durability to ... 3-high, and the uniformity and ... shake" applications. Heavily built ... our stackers are designed for ...
Dedicated 29.5" X 18" platforms for Stackable shakers. These platforms are optimized for a particular flask clip size and are sold with a full load of flask clips....
... Orbital Shakers combine high durability and ... power. The patented triple-counterbalanced heavy-duty ... to run with heavy out-of-balance loads. ... reduces contamination. The heavy stainless ...
... Electroporator is a simple, easy to ... in bacterial and yeast applications. ... two voltages and either one mm, ... On pressing the pulse button the ...
Biology Products: